The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 52 | — | 20.1x | Near average | |
Growth | 32 | -100.0% | 5.6% | Below average | |
Quality | 13 | -70.7% | 7.6% | Below average | |
Safety | 23 | 0.9x | 0.4x | Below average | |
Capital Return | 37 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Oculis Holding AG is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Oculis Holding AG shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Oculis stock has experienced a sharp revision in its average target price, dropping from $57.33 to $39.4, representing a 31.28% decline over the past 30 days. This adjustment coincided with an increase in the number of analysts from 3 to 6, suggesting that the entry of new opinions has led to a rationalization of previous excessive expectations and a reduction in unrealistic optimism, despite continued 'Buy' ratings from institutions such as Guggenheim and H.C. Wainwright.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.